Regenerex Pharma (Regenerex Pharma) EV-to-EBITDA : 0.00 (As of May. 25, 2024)

Regenerex Pharma EV-to-EBITDA Chart

Regenerex Pharma Annual Data
	Trend	Nov09	Nov10	Nov11	Nov12	Nov13	Nov14	Mar17	Mar18	Mar22	Mar23
EV-to-EBITDA		Get a 7-Day Free Trial					-	-	-	-	-

Regenerex Pharma Quarterly Data
	May14	Aug14	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Regenerex Pharma's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's EV-to-EBITDA falls into.

Regenerex Pharma EV-to-EBITDA Calculation

Regenerex Pharma's EV-to-EBITDA for today is calculated as:

Regenerex Pharma's current Enterprise Value is $0.00 Mil.
Regenerex Pharma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerex Pharma  (OTCPK:PEPT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Regenerex Pharma's PE Ratio for today is calculated as:

Regenerex Pharma's share price for today is $0.00.
Regenerex Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Regenerex Pharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma (Regenerex Pharma) Business Description